U.S. Pharmaceuticals & Biotech Most Popular Stocks

Ampio Pharmaceuticals

Market Cap: US$2.4k

A biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.

PaxMedica

Market Cap: US$2.3k

A clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.

RegeneRx Biopharmaceuticals

Market Cap: US$2.1k

A biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration.

AJ1G

Market Cap: US$2.0k

Global Consortium Inc. operates as a diversified cannabis holding company in Florida.

PAO Group

Market Cap: US$1.9k

Focuses on alternative patient care treatments.

Juva Life

Market Cap: US$1.6k

Acquires, owns, and operates in cannabis business in medical and recreational cannabis sectors in California, the United States.

Innoveren Scientific

Market Cap: US$1.6k

A medical bioscience company that develops technology in regenerative medicine for limb salvage.

MedMen Enterprises

Market Cap: US$1.6k

Operates as a cannabis retailer in the United States.

Kali

Market Cap: US$1.5k

Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses.

Parallel Industries

Market Cap: US$1.3k

Does not have significant operations.

South American Gold

Market Cap: US$1.3k

South American Gold Corp. is focused on becoming the premiere provider of value added products and services for the cultivation and processing of cannabis for the South American medical and recreational markets with an initial focus on the Uruguayan market.

DNAPrint Genomics

Market Cap: US$1.3k

Engages in the development and marketing of genetic testing products and services.

Viropro

Market Cap: US$1.3k

Through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases.

Invictus MD Strategies

Market Cap: US$1.2k

Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada.

BioSyntech

Market Cap: US$1.2k

Develops biotherapeutic thermogels for tissue repair and therapeutic delivery.

Adhera Therapeutics

Market Cap: US$1.2k

A biotech company, focuses on the discovery, development, and commercialization of small molecule drugs.

Pilot Therapeutics Holdings

Market Cap: US$1.2k

Pilot Therapeutics Holdings Inc. develops and manufactures pharmaceutical products for treatment of dysfunctional lipid metabolism.

GlobeImmune

Market Cap: US$1.2k

A biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform.

Arrayit

Market Cap: US$1.1k

A life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide.

Manzo Pharmaceuticals

Market Cap: US$1.1k

A specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies.

BellRock Brands

Market Cap: US$1.1k

Develops, markets, and sells cannabis products in the United States, Canada, and internationally.

Rising BioSciences

Market Cap: US$1.1k

Develops and manufactures topical and oral pharmaceutical products, including medical marijuana products.

Molecular Pharmacology (USA)

Market Cap: US$999.0

Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States.

Omnimmune Holdings

Market Cap: US$980.0

Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States.

BioELife

Market Cap: US$940.0

Operates in cannabinoid market.

Advantis

Market Cap: US$878.0

Develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors.

Praxsyn

Market Cap: US$847.0

A health care company, provides medical practitioners with medications and services for their patients.

Sunniva

Market Cap: US$795.0

A vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States.

Profile Solutions

Market Cap: US$776.0

Through its subsidiary, Elite Products International, Inc., manufactures and distributes cannabinoid hemp extracts in the form of edibles, creams, oils, and salves.

Item 9 Labs

Market Cap: US$701.0

Operates as a vertically integrated cannabis operator and dispensary franchisor in the United States.

Pathfinder Cell Therapy

Market Cap: US$667.0

A development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage.

Stem Holdings

Market Cap: US$666.0

Does not have significant operations.

NanoLogix

Market Cap: US$651.0

A biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms.

Amarantus BioScience Holdings

Market Cap: US$630.0

A biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine.

Rosetta Genomics

Market Cap: US$592.0

Operates as a genomic diagnostics company worldwide.

MetaStat

Market Cap: US$587.0

A precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients.